Mergers & Acquisitions

CP responds to Norfolk Southern’s rejection of proposed combination

CP responds to Norfolk Southern’s rejection of proposed combination PR Newswire CALGARY, Dec. 4, 2015 CALGARY , Dec. 4, 2015 /PRNewswire/ – Canadian Pacific (TSX:CP) (NYSE:CP) is disappointed with Norfolk Southern Corp.’s (NS) rejection of its proposal to create an end-to-end North American rail network that would enhance competition and generate significant shareholder value. […]

Stock Analysts

Rising Rates Are Great for These 5 Regional Bank Stocks

The European Central Bank (“ECB”) cut its deposit rate by 10 basis points to -0.3% and extended its asset purchase program by six months to at least the end of March 2017, in order to overcome weak growth and lift inflation. This undermined the expectations of the market, which anticipated higher reduction in the deposit rate and a probable cut to the refinancing rate. However, with all eyes on the Federal Reserve’s next policy meeting to be held Dec 15–16, the monetary policy stimulus program of the ECB was overshadowed by the potential increase in interest rates in the U.S. […]

Stock Analysts

Marathon Petroleum Discloses $4.2B as 2016 Capital Budget

Marathon Petroleum Corporation MPC − a leading independent refiner, transporter and marketer of petroleum products − unveiled its capital investment plan for the year 2016. During the year, the company will likely invest $4.2 billion. Out of the total amount, Marathon Petroleum is expected to spend $1.5 billion on the refining and marketing business […]

Stock Analysts

RBS to Reconsider Ulster Bank Sale Post October Split-Off?

Per Bloomberg, The Royal Bank of Scotland Group plc RBS will once again consider the sale of Ulster Bank, its consumer banking business in Ireland. According to people familiar with the matter, such review is anticipated to commence next year, while a decision will likely be reached over the next two years. Notably, in 2014, the company had dropped its plans to dispose Ulster Bank owing to complexities in prospective integration, and consequently, higher selling cost. […]

Stock Analysts

Alcatel-Lucent’s IP/MPLS Technology Secures Polish Ports

Premium technology company Alcatel-Lucent ALU recently declared that it has successfully deployed a monitoring, information, management and control system based on Internet Protocol/Multi-Protocol Label Switching (‘IP/MPLS’) technology. This technology would help Poland’s maritime authorities enhance operational efficacy as well as safety at ports located near the Baltic Sea. […]

Stock Analysts

Progenics (PGNX) Reaches Target Enrolment in Azedra Study

Progenics Pharmaceuticals, Inc. PGNX announced that it has completed patient enrolment in a pivotal phase IIb study on Azedra for the treatment of patients with malignant or recurrent pheochromocytoma and paraganglioma. The study is being conducted under the Special Protocol Assessment (SPA) agreement with the FDA […]

Stock Analysts

IBM Reportedly Targets $1B in Revenues from SoftLayer

International Business Machines Corporation IBM is targeting $1 billion in revenues in 2016 from its cloud infrastructure business, SoftLayer, up from $700 million to $800 million expected for 2015, as per Bloomberg, which cited sources familiar with the matter. Bloomberg puts it as an “ambitious goal” that highlights the company’s attempts to grow its cloud business amid stiff competition from other tech giants like Microsoft Corporation MSFT , Alphabet Inc. […]

Stock Analysts

Cepheid, FIND Tie Up for Next-Gen Point-of-Care TB Diagnosis

California-based molecular diagnostics provider Cepheid CPHD recently entered into a new strategic agreement with long-term partner, Foundation for Innovative New Diagnostics (FIND), a non-profit organization aimed at offering affordable diagnostic products and services in developing countries. Financial terms of the deal have been kept under wraps. […]

Stock Analysts

Should You Dump Cepheid (CPHD) from Your Portfolio Now?

On Dec 4, 2015, we issued an updated research report on California-based molecular diagnostics provider – Cepheid CPHD . The company develops varied diagnostic assays that enable rapid, sophisticated molecular testing for organisms and genetic diseases by automating complex manual laboratory procedures. […]

Stock Analysts

SABESP Announces 20th Issue of Debentures worth R$500M

Brazilian utility service provider Companhia de Saneamento Basico do Estado de Sao Paulo SBS or SABESP recently announced its 20th issuance of simple, unsecured and non-convertible debentures worth approximately R$500 million. As disclosed, the single-series debenture offer, approved by SABESP’s board of directors on Nov 27, will be presented to a maximum of 75 professional investors. […]

Stock Analysts

Celanese Sells Atmospheric Emulsions Unit in Spain to IQOXE

Chemical and advanced materials maker, Celanese CE said that it has completed the sale of its atmospheric (vinyl and acrylics) emulsions unit in Tarragona, Spain to petrochemical company, IQOXE. Financial terms of the transaction were not divulged. Tarragona-based IQOXE specializes in the production of ethylene oxide, glycols and ethylene oxide derivatives […]